Protalix BioTherapeutics
PLX
#8648
Rank
โ‚น6.78 B
Marketcap
โ‚น92.28
Share price
-4.35%
Change (1 day)
-35.09%
Change (1 year)

Protalix BioTherapeutics (PLX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚น5.28 B

According to Protalix BioTherapeutics 's latest financial reports the company's total liabilities are โ‚น5.28 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Protalix BioTherapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น4.23 B-22.97%
2022-12-31โ‚น5.49 B-7.45%
2021-12-31โ‚น5.93 B-14.34%
2020-12-31โ‚น6.93 B-15.81%
2019-12-31โ‚น8.23 B3.86%
2018-12-31โ‚น7.93 B22.16%
2017-12-31โ‚น6.49 B3.61%
2016-12-31โ‚น6.26 B9.17%
2015-12-31โ‚น5.73 B-32.3%
2014-12-31โ‚น8.47 B-2.21%
2013-12-31โ‚น8.66 B92.87%
2012-12-31โ‚น4.49 B9.1%
2011-12-31โ‚น4.11 B20.84%
2010-12-31โ‚น3.40 B-11.59%
2009-12-31โ‚น3.85 B1100.08%
2008-12-31โ‚น0.32 B83.05%
2007-12-31โ‚น0.17 B46.58%
2006-12-31โ‚น0.11 B135.52%
2005-12-31โ‚น50.85 M1720.99%
2004-12-31โ‚น2.79 M-22.34%
2003-12-31โ‚น3.59 M-5.18%
2002-12-31โ‚น3.79 M1.7%
2001-12-31โ‚น3.72 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น51.75 B 879.94%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น66.76 B 1,164.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น10.756 T 203,553.17%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.917 T 55,134.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel